BDBM50302627 (S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-morpholinopiperidin-1-yl)-2-phenylpyrimidine-4-carboxamido)-5-oxopentanoic acid::CHEMBL569995

SMILES CCCCOC(=O)N1CCN(CC1)C(=O)[C@H](CCC(O)=O)NC(=O)c1cc(nc(n1)-c1ccccc1)N1CCC(CC1)N1CCOCC1

InChI Key InChIKey=PSGPLKHMMLCGSB-MHZLTWQESA-N

Data  1 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50302627   

TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302627((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-m...)
Affinity DataKi:  1.30nMAssay Description:Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302627((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-m...)
Affinity DataIC50:  880nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed